AVIR
Atea Pharmaceuticals, Inc.
Halal Rating :
See Details
Last Price
$3.03
Last updated:
Market Cap
$280.22m
7D Change
-0.49%
1 Year Change
-47.48%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 6, 2023
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapies for patients suffering from viral infections. The company is headquartered in Boston, Massachusetts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $3.7m | $35.23m | $7.3m | $3.7m | 197.54% | 10.49% |
| March 31, 2023 | $3.09m | $41.57m | $6.3m | $3.09m | 204.05% | 7.43% |
| Dec. 31, 2022 | $3m | $39.9m | $5.59m | $3m | 186.37% | 7.52% |
Company Impact
Help us evaluate Atea Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.